Susha Cheriyedath

Susha Cheriyedath

Feature Writer

B.Sc Chemistry, M.Sc. Biochemistry

Susha is a scientific communication professional holding a Master's degree in Biochemistry, with expertise in Microbiology, Physiology, Biotechnology, and Nutrition. After a two-year tenure as a lecturer from 2000 to 2002, where she mentored undergraduates studying Biochemistry, she transitioned into editorial roles within scientific publishing. She has accumulated nearly two decades of experience in medical communication, assuming diverse roles in research, writing, editing, and editorial management.

See more

Passionate about health and nutrition, Susha is interested in various diet types, such as veganism, and their impact on the body and metabolism. She remains dedicated to staying current with the latest developments in the medical and health science fields. In her leisure time, she engages in gardening, cooking/baking, and sketching/painting. When not immersed in work, she can often be found tending to her garden (weather permitting) or engrossed in her sketching and painting projects.

See less

Articles from Susha

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Nucleic acid-hydrolyzing scFv 3D8 exhibits potent antiviral effects on SARS-CoV-2

Mexican case study finds similar mortality rates in diabetic patients with and without COVID-19

Mexican case study finds similar mortality rates in diabetic patients with and without COVID-19

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

Ipom-F inhibits SARS-CoV-2 infection in vitro

Ipom-F inhibits SARS-CoV-2 infection in vitro

Novel early-warning framework for evaluating control and elimination of SARS-CoV-2 in NZ

Novel early-warning framework for evaluating control and elimination of SARS-CoV-2 in NZ

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

BCG vaccination appears to trigger cross-reactive SARS-CoV-2-specific T cell response

Disproportionate COVID-19 mortality in England linked to non-white ethnicity and poverty

Disproportionate COVID-19 mortality in England linked to non-white ethnicity and poverty

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Analysis shows social distancing helped reduce nosocomial SARS-CoV-2 transmission in London

Analysis shows social distancing helped reduce nosocomial SARS-CoV-2 transmission in London

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.